Wall Street Zen downgraded shares of AirSculpt Technologies (NASDAQ:AIRS – Free Report) from a buy rating to a hold rating in a research report report published on Saturday morning.
A number of other research firms also recently commented on AIRS. Weiss Ratings raised AirSculpt Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, July 1st. Leerink Partners set a $4.50 price target on AirSculpt Technologies in a report on Thursday, May 14th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Reduce” and a consensus target price of $4.50.
Get Our Latest Research Report on AIRS
AirSculpt Technologies Stock Performance
AirSculpt Technologies (NASDAQ:AIRS – Get Free Report) last issued its quarterly earnings results on Monday, August 10th. The company reported $0.01 EPS for the quarter, missing the consensus estimate of $0.02 by ($0.01). The company had revenue of $42.90 million for the quarter, compared to the consensus estimate of $44.14 million. AirSculpt Technologies had a negative return on equity of 5.83% and a negative net margin of 7.79%.
Institutional Trading of AirSculpt Technologies
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Vesey Street Capital Partners L.L.C. bought a new stake in shares of AirSculpt Technologies in the 2nd quarter worth approximately $136,458,810,000. BlackRock Inc. acquired a new stake in AirSculpt Technologies in the second quarter worth $5,755,000. Renaissance Technologies LLC acquired a new stake in AirSculpt Technologies in the fourth quarter worth $1,991,000. Flputnam Investment Management Co. bought a new stake in AirSculpt Technologies in the second quarter valued at $3,114,000. Finally, Balyasny Asset Management L.P. lifted its stake in AirSculpt Technologies by 128.5% in the second quarter. Balyasny Asset Management L.P. now owns 1,113,843 shares of the company’s stock valued at $5,380,000 after buying an additional 626,309 shares during the last quarter. 91.54% of the stock is currently owned by institutional investors and hedge funds.
AirSculpt Technologies Company Profile
AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.
Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.
Featured Articles
- Five stocks we like better than AirSculpt Technologies
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Receive News & Ratings for AirSculpt Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AirSculpt Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
